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Adipose tissue around lymph nodes is usually removed prior to the study of immune activity—but is it time to
reconsider this practice? Perinodal adipose tissue may provide not only a specific lipid resource but also fatty
acids, dendritic cells, and soluble mediators that modulate local immunity.Dietary fats influence immunity—but how
are these effects targeted to the immune
system, and how is immune activity buff-
ered from the immediate effects of current
dietary components? Perinodal adipose
tissue (PAT) is in the form of small depots
or regions of larger depots of stored fat in
which lymph nodes are embedded and is
a unique and conserved feature of mam-
malian anatomy. The specialized proper-
ties of this PAT provide a local resource
that interacts with the lymph node and
appears to form a buffer of stored adipose
tissue dedicated to the functioning of the
lymph node. There is increasing evidence
that adipose tissues do not merely pro-
vide an energy resource but are also
specialized to contribute to local physio-
logical mechanisms. To this purpose,
they are not homogeneous but show
site-specific properties. One example of
site-specific specialization of white adi-
pose tissue is that of pericardial fat, which
is highly adapted as a local energy re-
source with its small adipocyte size, high
rates of fatty-acid incorporation and
synthesis, and insulin-induced fatty-acid
breakdown (Rabkin, 2007). Another ex-
ample of this specialization is seen in the
close physiological relationship between
adipose tissue surrounding breast cancer
and the tumor itself, with evidence of en-
docrine and paracrine mechanisms that
connect adiposity and breast cancer
(Schaffler et al., 2007). However, the
most detailed evidence for major adapta-
tion and site-specific properties in normal
white adipose tissues is described for
PAT. Indeed, the specialized properties
of PAT mean that this tissue not only
acts as a dedicated lipid resource fueling
immune activation in lymph nodes but
also provides key fatty-acid, cellular, andadipokine immunoregulatory materials
that support and regulate local immunity
(Figure 1). Conversely, antigenic stimula-
tion and activity of cells of the immune
system may influence adiposity. Here I
highlight a few examples of the close
interaction between PAT and local lymph




The nature of the fatty-acid content of
PAT is one aspect showing site-specific
specialization. In humans, PAT has a sub-
stantially higher content of polyunsatu-
rated fatty acids (PUFAs) than adipose
tissue distal from the node, including the
subcutaneous tissues (Westcott et al.,
2005). A similar distribution of fatty acids
occurs in rodents, in which PUFA-rich
fats, released by lipolysis from triacylgly-
cerols in PAT, appear to be taken up into
lymph nodes and are incorporated in lym-
phoid cells after immune stimulation.
There is a two-way interaction between
PAT and the lymphoid tissue it encircles.
Activated lymphocytes can promote
glycerol release from PAT but have little
effect on adipocytes from other sites.
Conversely, PAT, but not adipose tissue
from other sources, is able to reduce lym-
phocyte proliferation in vitro (Pond [2003]
for references). The immunomodulatory
effects of PUFAs are well described,
with omega 3 and omega 6 PUFAs and
their metabolic products often being im-
munosuppressive although, in some in-
stances, omega 6 PUFAs may potentiate
immunity. Possible mechanisms of action
of PUFAs or their metabolites on the im-
mune system include modulation of cellu-
lar-membrane fluidity and raft formation,Immunitsignal transduction, and/or gene expres-
sion, affecting functions such as antigen
presentation and cell migration (Sijben
and Calder [2007] for references).
Site-specific changes of fatty acids
within PAT are likely to have a major im-
pact on the local immune system. Crohn’s
disease, an inflammatory disease of the
gut, possibly resulting from an abnormal
response to gut microbiota, is character-
ized by hypertrophy of mesenteric adi-
pose tissue. A feature of this disease is
the absence of selective accumulation of
PUFAs in PAT and of the correlation
between fatty-acid content of PAT and
lymph node cells (Westcott et al., 2005).
These changes suggest that the normal
immunomodulatory nature of fatty acids
stored in PAT can be lost in inflammatory
disease.
Soluble Mediators and PAT
A second and related specialization of
PAT is its sensitivity to and production of
cytokines. The general relationships be-
tween cytokines or adipokines within
adipose tissues and the immune system
have been extensively discussed (Ha-
senkrug, 2007; Tilg and Moschen, 2006).
However, PAT is exquisitely equipped
for local interactions with lymphoid tis-
sues. For example, cytokines such as
tumor necrosis factor-a and interleukin-6
(IL-6), to both of which PAT is especially
responsive, are key modulators in the
development of immunity, can promote
migration of dendritic cells (DCs) into
lymph nodes, and are involved in re-
sponses to bacterial antigens, particularly
during early stages of immune responses
(Hasenkrug, 2007; Tilg and Moschen,
2006). These cytokines have minimal ef-
fects on lipolysis of perirenal or gonadaly 28, February 2008 ª2008 Elsevier Inc. 135
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release from PAT (Pond, 2003), which
may thus provide a resource to support
local immune activity. However, when
IL-4 is also present, glycerol release is
suppressed, particularly in PAT, so that
alterations in local cytokines together
with related variations in sensitivity of
PAT adipocytes may combine to produce
changes in local immune activity (Pond,
2003). IL-4 can also prevent synthesis
of prostaglandin E2 (PG E2) from its
fatty-acid precursors but can induce ex-
pression of PPAR-g (a key regulator of
adipocyte differentiation and lipid metab-
olism) and promote the oxygenation of
free PUFAs, which generates PPAR-g
ligands. These effects are likely to reduce
DC maturation and activity because PGE2
can promote DC differentiation and matu-
ration whereas PPAR-g may be anti-
inflammatory, blocking DC maturation
(Thurnher, 2007). Such effects are partic-
ularly relevant to PAT because PAT and
not adipose tissue from elsewhere con-
tains DCs (see below). PAT adipocytes
are also more sensitive to noradrenalin,
and their maximum rate of lipolysis is
higher than those at other sites (Pond,
2003). Adipokines produced specifically
within adipose tissues also affect immune
stimulation. For example, adiponectin
generally has immunoregulatory proper-
ties, whereas leptin, in addition to its role
in energy homeostasis, can act as a proin-
flammatory cytokine.(Hasenkrug, 2007;
Tilg and Moschen, 2006). Thus, cytokines,
in concert with the local fatty-acid milieu,
may modulate inflammation in part by ef-
fects on maturation and function of DCs.
Immune Cells in PAT
A third specialization found in normal PAT
is the presence of high numbers of DCs.
The presence of DCs is a particular prop-
erty of adipose tissue containing lym-
phoid structures and can be modulated
by antigenic stimulation, diet, and dis-
ease. Omentum is the adipose tissue as-
sociated with the spleen in mice and is
a larger organ in humans, hanging like
an apron in the abdomen and containing
embedded pockets of lymphoid cells.
Omental tissue in humans contains large
numbers of DCs identified by morphol-
ogy, phenotype, and stimulatory function,
whereas normal subcutaneous fat con-
tains virtually no DC (Bedford et al.,
2006). In rodents, putative DCs are also
found in PAT, but, again, few are found
in fat distal from the nodes or in subcuta-
neous fat. The presence of these large
mononuclear cells increases on antigenic
stimulation, and their numbers are moder-
ated by the presence of a diet high in
omega 3 fatty acids (Mattacks et al.,
2004). In addition to the DCs, there are
stem cells present in PAT (Bedford et al.,
2006), as widely reported for other adi-
pose tissue depots. Preadipocytes also
have the potential to develop into macro-
phages (Charriere et al., 2003). Indeed,
there is increasing evidence for involve-
ment of adipose tissue macrophages in
obesity-related inflammation (Weisberg
et al., 2003; Wellen and Hotamisligil,
2003). DCs in adipose tissue can also
change in disease, as exemplified by
those in the omentum from patients with
Crohn’s disease; in addition to the reduc-
tion of stored PUFAs in PAT already
described, the numbers of bone-mar-
row-derived cells from omentum in
Crohn’s disease is increased 5-fold. Sub-
stantial numbers of granulocytes, not
seen in control PAT, are present, but
a high proportion of the cells have a DC
morphology and phenotype. These cells
express increased amounts of costimula-
tory molecules, suggesting innate activa-
tion of DCs in Crohn’s disease, although
MHC class II and stimulatory function for
T cells are lost (Bedford et al., 2006).
These changes suggest that DCs from
PAT may contribute to or reflect changes
in local immune activity in inflammatory
disease. DCs can take up large amounts
of lipid on stimulation (Maroof et al.,
2005) and may provide a major route via
which fatty acids and their metabolic
products stored in PAT both provision
and exert their immunoregulatory proper-
ties within the lymph node.
Adipose Tissue and Responses
to Antigens
The provision of a local lipid resource that
supports immune activity appears to have
evolved coordinately with recognition
structures for responses to antigenic stim-
ulation; clearly, recognition of antigenic
differences is impotent without resources
to provision an immune response. Where
Figure 1. Perinodal Adipose Tissue Is Specialized to Provide Fatty Acids, Adipokines, and
Dendritic Cells that May Influence Local Immune Responses
PAT is higher in polyunsaturated fatty acids than adipose tissue distal from nodes and may downregulate
lymphocyte activation. PAT also contains adipokines that may influence immune activity. Afferent
lymphatic vessels enter PAT and divide before entering through the lymph node capsule into the subcap-
sular sinus of the lymph node. Dendritic cells (DCs) enter lymph nodes via afferent lymph and are found in
abundance in PAT but are not present in adipose tissue distal from the lymph node or in subcutaneous
adipose tissue.
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Commentaryfatty acids or their metabolites can also
cause immunomodulation, such re-
sources are likely to evolve in concert
with immune recognition to be utilized for
the benefit of either the host or an invading
organism. This concept is supported by
the evidence that genes involved in the im-
mune system, in nutrition, and in the func-
tion of adipose tissue have been subject
to recent selection in human populations
(Voight et al., 2006). Thus, many receptors
for antigens on myeloid cells interact with
lipids or their metabolites, an interaction
that may influence both immune activity
and lipid homeostasis. One example of di-
rect effects of fatty acids is seen in the
modulation they cause via receptors for
bacterial antigens, the Toll-like receptors
(TLRs). Signaling through TLRs induces
in DCs innate immune responses that in
turn link to adaptive immune responses.
Saturated fatty acids may promote activa-
tion via TLRs, whereas n-3 PUFAs inhibit
agonist-induced TLR activation, suggest-
ing that differential modulation of immune
responses occurs. Indeed, the saturated
fatty acid, lauric acid, upregulates the
expression of costimulatory molecules
(CD40, CD80, and CD86), MHC class II,
and cytokines (IL-12p70 and IL-6) in
bone-marrow-derived DCs via TLR acti-
vation. This activation produces increases
in the capacity to stimulate T cells (Weath-
erill et al., 2005). In contrast, the n-3 poly-
unsaturated fatty acid, docosahexaenoic
acid, normally more abundant in PAT
than in other adipose tissues, inhibits
the TLR4-agonist-induced upregulation
(Thurnher, 2007). The activation of TLR4
signaling in adipocytes and macrophages
by nutritional fatty acids is confirmed in
mice from the blunting of inflammatory
signals they induce in the absence of
TLR4 (Shi et al., 2006). The relatively high
amounts of PUFAs normally in PAT would
tend to downregulate signaling through
TLRs. In the PAT of subjects with Crohn’s
disease, there are increases in the propor-
tion of saturated fats, including palmitic
acid, which can also promote TLR-in-
duced activation in DC (Lee et al., 2001;
Westcott et al., 2005). This increase in sat-
urated fatty acids is likely to combine with
the presence of a proinflammatory micro-
biota to promote local inflammatory ac-
tivity in this disease. Increased IL-6 also
would promote lipolysis of local adipo-
cytes, thereby releasing glycerol for utili-
zation as an energy substrate. Dietary fattyacids and those stored around lymph
nodes may, therefore, play a seminal role
in differential modulation of local immune
activity and alter the effects induced by
exogenous and endogenous antigens. Di-
etary PUFAs and their longer-term effects
on changes in the fatty acids stored
around lymph nodes are, thus, likely to
be implicated in susceptibility to and ac-
tivity of many chronic diseases via effects
acting locally through antigen receptors
such as the TLRs.
Some effects of PUFAs may be less di-
rect and are mediated by metabolic prod-
ucts of the fatty acids that share receptors
with antigens. The activities of prostaglan-
dins and leukotrienes have been widely
reported and have effects on the matura-
tion and function of DC. Many lipids or
their metabolites also affect the migration
of lymphocytes and DC, and these include
PGE2, leukotrieneC4, and sphigosine-
1-phsophate (Thurnher, 2007). Resolvins
represent a more recently described cate-
gory of fatty-acid-derived immune modu-
lators that can interact with a receptor for
antigen on DC and may also influence
the migratory properties of the DCs.
ChemR23 is a G protein-coupled receptor
expressed on DCs, particularly those of
the CD11c (plasmacytoid) subset (Zabel
et al., 2005). This molecule is a coreceptor
for human and simian immunodeficiency
virus (Martensson et al., 2006). Two major
innate ligands for this receptor have been
identified. The first is the RARRES2 gene
product, chemerin, expressed as an inac-
tive protein precursor, which is activated
in situ at sites of inflammation. In vitro,
chemerin stimulates ChemR23+ dendritic
cells to migrate across epithelial cell
layers. The second ligand for ChemR23
is Resolvin E1 and is derived from omega
3 PUFAs, which are found in increased
quantities in PAT. Resolvin E1 blocks
migration of DC to chemerin. Early in vivo
experiments involving animal models of
inflammatory disease, such as inflamma-
tory bowel disease, imply a therapeutic
role for resolvin E1 in improving outcome
(Arita et al., 2005). This unique chemotac-
tic axis provides an added explanation for
the benefit and therapeutic role of omega
3 polyunsaturated fatty acids and their de-
rivatives such as resolvinE1. Conversely,
the link with human and simian immuno-
deficiency virus indicates that ChemR23
is a ‘‘minor receptor,’’ but retrovirally
induced blocking of DC migration hasImmunitbeen reported in animal models of HIV
infection (Gabrilovich et al., 1994), and
one can question whether this receptor
sharing might provide a mechanism by
which the virus could block a normal
migration pathway of DC.
Effects of Antigenic Stimulation
on Local Adiposity
The examples of coordinate evolution of
antigen receptors and receptors for fatty
acids and their derivatives so far outlined
have concentrated on the possible impli-
cations for the functioning of the immune
system. However, the other side of this
equation is the reciprocal effects that
antigenic stimulation may have on adi-
posity and energy homeostasis. Exposure
to some bacterial antigens, such as endo-
toxin, or viral antigens, including those of
adenoviruses, can promote obesity (Cani
et al., 2007; Tsukumo et al., 2007; Wellen
and Hotamisligil, 2003; Whigham et al.,
2006), providing support for two-way
interactions between immune activation
and adipose tissue. An example that
may relate directly to the shared receptor
for antigen and fatty acid, TLR4, is the
observation that diet-induced obesity
can be associated with LPS stimulation
and is moderated in TLR4-deficient mice
(Cani et al., 2007; Tsukumo et al., 2007).
Other changes in adiposity link specifi-
cally to the specialized function of PAT,
e.g., lipodystrophy that occurs in some
HIV patients on treatment with proteinase
inhibitors, and hypertrophy of PAT in
rodents during prolonged mild antigenic
stimulation (Pond, 2003). It is these PAT
depots that become enlarged in the HIV-
positive patients, with or without atrophy
of non-PAT depots. Retroviral infection
is known to make DCs alter their secretion
of some of the cytokines to which perino-
dal adipocytes respond (Pond, 2003).
Thus, the proposed relationship between
adipose tissue and the immune system
can also be used to explain the redistribu-
tion and hypertrophy of adipose tissue
that takes place after a long period of
chronic inflammation such as that which
characterizes the mesenteric adipose
tissues in Crohn’s disease and PAT in
HIV infection.
Conclusions and Perspectives
PAT is a preserved feature of mammals. It
has site-specific properties adapted to
allow contributions of stored fatty acids,y 28, February 2008 ª2008 Elsevier Inc. 137
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kines, and contains large numbers of anti-
gen-presenting dendritic cells. All of these
factors have the potential to influence
local immunity. For immunologists study-
ing the immune activity of the lymph
nodes, removal of PAT may avoid the re-
lease of fats that make cell handling prob-
lematic. However, although this maneu-
ver undoubtedly has helpful technical
consequences, it may mean that a major,
integrated part of the immune system is
lost. PAT is clearly not just a load of incon-
venient lard but is also a fully active part-
ner to the lymph node, resourcing and
regulating immunity. Exciting questions
emerge from this new perspective.
Changes in the properties of PAT in in-
flammatory bowel disease demonstrate
the potential of perinodal adipose tissue
to influence immune status and vice
versa. However, to what extent do differ-
ent antigens, infections, and immunologi-
cal diseases contribute to variations in
PAT composition? Diet, influenced by
the gut microbiota, is obviously the ulti-
mate resource for many lipids that influ-
ence immune activity. For dietary lipids
to be utilized effectively, they have to
reach the right location in PAT. What are
the mechanisms that ensure that the right
type of adipose tissue is stored in the peri-
nodal area? What is the source of local
DCs within adipose tissue? Finally, how
are locally stored lipids and their products
and adipokines taken up and utilized by
the local cells of the immune system?
Many receptors for antigens on myeloid
cells, including those for bacterial and
viral antigens, interact with lipids or their
metabolites to influence local immune
activity. Conversely, there is increasing
evidence that antigenic stimulation and
responsiveness can influence energy
homeostasis and obesity. The coevolu-
tion of antigen recognition, the energy
resource required to provision immune
activation, and the immunomodulatory
function of involved adipose tissue and
its metabolites forms a natural integration
of factors that are likely to contribute both
to adiposity and to the optimal functioning
of the local immune system. However,
many of the details of these interactions
remain tantalizingly vague.138 Immunity 28, February 2008 ª2008 ElseACKNOWLEDGMENTS
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